Quantcast
Last updated on April 18, 2014 at 17:24 EDT

Latest Alzheimer's Stories

2014-03-05 16:26:16

Study attributes more than 500,000 annual deaths to Alzheimer's disease WASHINGTON, March 5, 2014 /PRNewswire-USNewswire/ -- Today, Neurology - the official journal of the American Academy of Neurology and a leading peer-reviewed publication - published a groundbreaking study from researchers at the Rush Alzheimer's Disease Center in Chicago that attributes more than 500,000 deaths in 2010 to Alzheimer's disease - an amount more than six times the number reported by the Centers for...

2014-03-05 12:27:31

LEARN Project will Track Cognitive Change in a Comparison Group of Older Individuals, and Initiate the First Tau Imaging Study in a Longitudinal Prevention Trial CHICAGO, March 5, 2014 /PRNewswire-USNewswire/ -- The Alzheimer's Association today announced its largest ever research grant - $8 million over four years - to support the Longitudinal Evaluation of Amyloid Risk and Neurodegeneration (LEARN) study as a companion study to the Anti-Amyloid Treatment in Asymptomatic Alzheimer's...

2014-02-26 16:29:58

WASHINGTON, Feb. 26, 2014 /PRNewswire-USNewswire/ -- Today, the Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies held a hearing dedicated to the economic impact of Alzheimer's disease in America. Chaired by Senators Tom Harkin (D-IA) and Jerry Moran (R-KS), the hearing also examined the current state of biomedical research into prevention and treatment of the disease. National Institutes of Health (NIH) Director Dr. Francis Collins,...

2014-02-20 20:24:06

New platform will link eligible candidates to clinical trials around the world WASHINGTON, Feb. 20, 2014 /PRNewswire-USNewswire/ -- The Global CEO Initiative (CEOi) on Alzheimer's Disease and the New York Academy of Sciences today convened representatives from industry, academia, government and nonprofits to launch the development of a Global Alzheimer's Platform (GAP), designed to reduce the time and costs of Alzheimer's clinical trials, develop an infrastructure that promotes innovation,...

2014-02-20 12:27:47

Takeda will advance the CEOi's goal of building global momentum behind the G8's 2025 commitments WASHINGTON, Feb. 20, 2014 /PRNewswire-USNewswire/ -- The Global CEO Initiative (CEOi) on Alzheimer's Disease today announced that Takeda Pharmaceutical Company Limited ("Takeda") will join the CEOi as part of its effort to spur innovations in research and accelerate a means of prevention for Alzheimer's and Dementia, building momentum behind the G8's commitment to stop the disease by...

2014-02-18 12:29:49

Home Instead to advance global momentum triggered by G8 Dementia Summit to improve care for families touched by Dementia WASHINGTON, Feb. 18, 2014 /PRNewswire-USNewswire/ -- The Global CEO Initiative (CEOi) on Alzheimer's Disease today announced that Home Instead Senior Care© - the world's leading provider of in-home care services for seniors will join the CEOi to advance the quality of care for those suffering from Alzheimer's and Dementia. Through its diverse group of leading...

2014-02-12 12:30:19

Eli Lilly, the Sole Competitor in 2013, Will Be Joined by GE Healthcare, Piramal Enterprises and Navidea Biopharmaceuticals in the Next Few Years, According to Findings from Decision Resources Group BURLINGTON, Mass., Feb. 12, 2014 /PRNewswire/ -- Decision Resources Group finds that the United States Alzheimer's imaging agent market will grow dramatically over the next 10 years. Currently, Eli Lilly's Amyvid, launched in June 2013, is the only Food and Drug Administration...

2014-02-07 16:24:27

HARRISBURG, Pa., Feb. 7, 2014 /PRNewswire-USNewswire/ -- Secretary of Aging Brian Duke today presented the Pennsylvania State Plan for Alzheimer's Disease and Related Disorders to Governor Tom Corbett on behalf of the members of the Pennsylvania Alzheimer's Disease Planning Committee, completing the group's year-long process to study the state's response to the disease and develop a plan to address it. Governor Corbett established the 26-member committee by executive order on Feb. 7,...

2014-02-05 12:27:55

Mounting Evidence of Biological Similarities Inspires Funding Program to Advance Understanding of Two Most Common Brain Diseases CHICAGO, NEW YORK and TORONTO, Feb. 5, 2014 /PRNewswire-USNewswire/ -- As research unveils overlap in the biology -- in addition to long-noted shared clinical symptoms -- of Parkinson's and Alzheimer's diseases, three non-profit organizations are uniting to encourage further study into the similarities and differences between the two most common brain diseases,...

2014-02-03 12:29:31

Clinical research team meets with principal investigators in St Petersburg as a clinical trial of the first tau aggregation inhibitor (TAI) in Phase 3, aimed at halting the progression of Alzheimer's, gets underway in Russia ALBANY, N.Y., Feb. 3, 2014 /PRNewswire/ -- A doctor-and-nurse team from the Neurological Associates of Albany clinic will travel to St Petersburg, Russia, next month to meet with clinical research doctors about TauRx Therapeutics' global Phase 3 clinical trial...